ARO-ANG3

· Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ARO-ANG3, covering 2024-01-16 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients [Phase 1]